About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Medicamen Biotech Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
531146
ISIN Demat
INE646B01010
Book Value
189.75
NSE Code
MEDICAMEQ
Dividend Yield %
0.29
Market Cap
4709.69
P/E
53.28
EPS
6.52
Face Value
10
BSE
NSE
04-Sep-2025
BSE
NSE
NSE F & O
04-Sep-2025
BSE
NSE
NSE F & O
Last Price
347.25
Net Change
-4.2
% Change
-1.2%
Prev.Close
351.45
Open
351.45
High
361.15
Low
345.00
Volume
1344
Last Price
346.60
Net Change
-3.95
% Change
-1.13%
Prev.Close
350.55
Open
354.05
High
362.00
Low
344.55
Volume
14880
Value
470214
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
361.15
52-Week High
630.00
52-Week Low
341.20
Value
5221754.2
Best Buy
0.00
Best Sell
346.60
Best Quantity
0
Sell Quantity
145
Today's Range
362.00
52-Week High
630.00
52-Week Low
341.70
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
145
Price
346.60
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
20-Sep-24
26-Sep-24
Dividend
10 %
20-Sep-24
Company News
03-06-2025
Medicamen Biotech gets US...
03-04-2025
Medicamen Biotech signs c...
31-03-2025
Medicamen Biotech informs...
22-03-2025
Medicamen Biotech informs...
10-03-2025
Medicamen Biotech enters ...
04-01-2025
Medicamen Biotech inform...
11-09-2024
Medicamen Biotech’s Bhiwa...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.